₹18.91 Crores | Listing at BSE | Mon, Feb 13, 2023 - Tue, Feb 21, 2023
Shree Ganesh Remedies Limited Rights Issue comprises 0.0840 Cr equity shares aggregating to ₹18.91 Cr, offered at an issue price of ₹225 per share with a face value of ₹10 per share.
The record date for determining eligible shareholders is Feb 3, 2023.
As per the terms of payment, ₹225 per share payable on application, with the balance payable in call(s).
The Rights Entitlements are expected to be credited to eligible demat accounts on Feb 15, 2023.
The Rights Issue opens on Feb 13, 2023 and closes on Feb 21, 2023.
The deemed date of allotment is Mar 1, 2023, following which the equity shares are expected to be credited to demat accounts on Mar 3, 2023 and listed on the BSE on Mar 8, 2023.
Fedex Securities Pvt.Ltd. is the Lead Manager to the issue and Bigshare Services Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Shree Ganesh Remedies Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Fri, Feb 3, 2023
Entitlement Ratio
:
Open Date
Mon, Feb 13, 2023
Close Date
Tue, Feb 21, 2023
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 60.6 | 51.18 | 9.75 | 49.44 |
| 31-Mar-22 | 77.02 | 74.86 | 13.4 | 55.79 |
| Amount in ₹ Crore | ||||
Incorporated in 1995, Shree Ganesh Remedies Limited is engaged in the business as a pharmaceutical intermediate manufacturing company in India. The company is engaged and involved in the development of Basic as well as Advanced intermediates for the API active pharmaceutical ingredients ("APIs"), for the generic and regulated market.
Extending its operations, Shree Ganesh Remedies recently entered into a new chemical entity ("NCE"), the synthesis of which is the first step in the process of drug development.
Shree Ganesh Remedies (SGRL) is an ISO 9001:2015, ISO 14001:2015 BS, and ISO 45001:2018 certified entity actively engaged in the manufacturing of pharma intermediates and fine chemicals. Products of the company are:
The products of Shree Ganesh Remedies are delivered across different parts of India alongside exported in other countries. The company is scaling its business continuously to tremendous heights.
The Company intends to utilize the Net Proceeds from the Issue towards the funding of the following objects:
[Dilip Davda] The company is in the pharma segment and has already migrated to the mainboard on BSE. However, its RI is fully priced based on its market trade data. The surge in its bottom lines for the last 21 months working raises eyebrows. Well-informed cash surplus investors may consider parking funds for long-term rewards. Read detail review...
Shree Ganesh Remedies Limited
Plot no. 6011,
G.I.D.C,
Ankleshwar - 393002
Ankleshwar, Gujarat, 393002
The Shree Ganesh Remedies Rights Issue 2023 opens on Mon, Feb 13, 2023, and closes on Tue, Feb 21, 2023.
Shree Ganesh Remedies Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | Wed, Feb 15, 2023 |
| Last Date for renunciation of Rights Entitlements | Wed, Feb 15, 2023 |
| Issue Opening Date | Mon, Feb 13, 2023 |
| Issue Closing Date | Tue, Feb 21, 2023 |
| Date of Allotment (on or about) | Wed, Mar 1, 2023 |
| Date of Credit (on or about) | Fri, Mar 3, 2023 |
| Date of Listing (on or about) | Wed, Mar 8, 2023 |
You can apply for Shree Ganesh Remedies Rights Issue 2023 in two ways:
Steps to apply for Shree Ganesh Remedies Rights Issue 2023 using Net Banking (ASBA)
Steps to apply for Shree Ganesh Remedies Rights Issue 2023 using Registrar's website (R-WAP)
